Ann Arbor-based University of Michigan’s Michigan Institute of Clinical & Health Research received $71 million to improve the process of translational research to deliver treatments to patients more quickly.
The hospital will use the grant to develop scientific and operational innovations to shorten the time of development and delivery of new treatments, according to an April 10 system news release. These solutions will be shared nationally.
The grant, from the National Center for Advancing Translational Science — which is part of National Institutes of Health, historically focused on helping research institutions build infrastructure to catalyze and support clinical and translational research at universities and other institutions. Now, the grant hopes to examine and improve the systems within translational research such as identifying barriers of bringing therapies to practice and addressing them.
On average, it takes more than 10 years to bring medications to market, and most drugs brought to clinical trials fail to produce any benefit for patients, according to the release.
